EVOLVE

Serial Number 97026259
Registration 7409113
700

Registration Progress

Application Filed
Sep 14, 2021
Under Examination
Sep 27, 2022
Approved for Publication
Aug 2, 2022
Published for Opposition
Aug 2, 2022
Registered
Jun 4, 2024

Basic Information

Serial Number
97026259
Registration Number
7409113
Filing Date
September 14, 2021
Registration Date
June 4, 2024
Published for Opposition
August 2, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 4, 2024
Registration
Registered
Classes
010

Rights Holder

Mallinckrodt Pharmaceuticals Ireland Limited

77
Address
Cruiserath Road, Blanchardstown
College Business & Technology Park
Dublin 15 D15TX2V
IE

Ownership History

Mallinckrodt Hospital Products IP Unlimited

Original Applicant
79
Dublin 15 IE

Mallinckrodt Hospital Products IP Unlimited

Owner at Publication
79
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

New Owner After Publication #1
77
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

Original Registrant
77
Dublin 15 IE

Legal Representation

Attorney
Caleb Norris

USPTO Deadlines

Next Renewal Deadline
1792 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-06-04)
Due Date
June 04, 2030
Grace Period Ends
December 04, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description
Jun 4, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
May 1, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 1, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 4, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Apr 4, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 20, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 14, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 14, 2024 IUAF S USE AMENDMENT FILED
Sep 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 18, 2023 EX2G S SOU EXTENSION 2 GRANTED
Sep 18, 2023 EXT2 S SOU EXTENSION 2 FILED
Sep 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 24, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2023 EX1G S SOU EXTENSION 1 GRANTED
Mar 22, 2023 EXT1 S SOU EXTENSION 1 FILED
Mar 22, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 PUBO A PUBLISHED FOR OPPOSITION
Jul 13, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 28, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED
Jun 28, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED
Jun 28, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 28, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jun 17, 2022 DOCK D ASSIGNED TO EXAMINER
Oct 20, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 010
Apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients
First Use Anywhere: Mar 13, 2024
First Use in Commerce: Mar 13, 2024

Classification

International Classes
010